Home » Stocks » AnPac Bio-Medical Science

AnPac Bio-Medical Science Co. Ltd. (ANPC)

Stock Price: $6.17 USD 0.29 (4.93%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 51.45M
Revenue (ttm) 1.55M
Net Income (ttm) -14.44M
Shares Out 11.20M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $6.17
Previous Close $5.88
Change ($) 0.29
Change (%) 4.93%
Day's Open 5.99
Day's Range 5.78 - 6.59
Day's Volume 3,029
52-Week Range 5.06 - 12.18

More Stats

Market Cap 51.45M
Enterprise Value 56.08M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 11.20M
Float 2.30M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.82
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 108
Short Ratio 0.05
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 33.21
PB Ratio n/a
Revenue 1.55M
Operating Income -12.73M
Net Income -14.44M
Free Cash Flow -7.34M
Net Cash -4.63M
Net Cash / Share -0.56
Gross Margin 44.24%
Operating Margin -821.41%
Profit Margin -931.90%
FCF Margin -473.86%
ROA -105.30%
ROE n/a
ROIC 5,136.30%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

Current: 6.17
Target: 18.00
*Average 12-month USD price target from 1 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Revenue Growth5.8%80.27%-
Gross Profit4.804.581.73
Operating Income-89.08-43.61-40.92
Net Income-101-42.06-39.08
Shares Outstanding8.948.527.94
Earnings Per Share-11.31-4.93-4.92
Operating Cash Flow-48.60-31.15-21.64
Capital Expenditures-2.792.84-2.60
Free Cash Flow-51.39-28.31-24.25
Cash & Equivalents6.1312.8911.41
Total Debt38.5725.9612.50
Net Cash / Debt-32.44-13.07-1.09
Book Value-15.97-22.399.56
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name AnPac Bio-Medical Science Co. Ltd.
Country China
Employees 111
CEO Chang Yu

Stock Information

Ticker Symbol ANPC
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ANPC


Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.